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Summary
Molecular mechanisms underlying the coordination
of isotype switching with plasma cell differentiation
are poorly understood. We show that interferon regu-
latory factor-4 (IRF-4) regulates both processes by
controlling the expression of the Aicda and Prdm1
genes, which encode AID and Blimp-1, respectively.
Genome-wide analysis demonstrated that Irf42/2 B
cells failed to induce the entire Blimp-1-dependent
plasma cell program. Restoration of AID or Blimp-1
expression in Irf42/2 B cells promoted isotype switch-
ing or secretion, respectively. IRF-4 was expressed in
a gradedmanner in differentiating B cells and targeted
Prdm1. Higher concentration of IRF-4 induced Prdm1
andconsequently the transition fromagerminal center
gene expression program to that of a plasma cell. We
propose a gene-regulatory network in which graded
expression of IRF-4 developmentally coordinates iso-
type switching with plasma cell differentiation.
Introduction
Upon antigen challenge, B lymphocytes undergo af-
finity maturation, isotype switching, and terminal diff-
erentiation into plasma cells that secrete antibodies
(McHeyzer-Williams, 2003). Considerable progress has
been achieved in the analysis of signaling molecules
and transcription factors that regulate these processes
(Shapiro-Shelef and Calame, 2005). Although many im-
portant components have been identified and geneti-
cally characterized, an understanding of their intercon-
nectivity in current regulatory networks is incomplete.
Furthermore, the molecular mechanisms underlying the
developmental coordination of isotype switching with
immunoglobulin secretion are poorly understood.
Plasma cell differentiation is regulated by the zinc-fin-
ger transcription factor Blimp-1 (encoded by the Prdm1
gene) and involves a dramatic expansion of the endo-
plasmic reticulum (ER) and increased protein synthesis,
both of which are necessary for high levels of antibody
production and secretion (Shapiro-Shelef and Calame,
2005; Turner et al., 1994). Blimp-1 represses the expres-
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3 These authors contributed equally to this work.sion of Pax5, which results in the derepression of Xbp1,
a gene that encodes a member of the CREB/ATF tran-
scription factor family (Lin et al., 2002; Reimold et al.,
1996). Xbp1 directly activates transcription of the genes
encoding chaperones and enzymes that function in the
secretory apparatus (Shaffer et al., 2004). In addition,
Blimp-1 regulates, in an Xbp1-independent manner,
the differential 30 end processing of the immunoglobulin
heavy chain pre-mRNA, which results in a transcript that
encodes the secreted polypeptide (Sciammas and Da-
vis, 2004; Shapiro-Shelef et al., 2003). Blimp-1 represses
the germinal center program, including the expression
of Bcl6 and Aicda (Sciammas and Davis, 2004; Shaffer
et al., 2002). Blimp-1 expression also results in upregu-
lation of both the chemokine receptor CXCR4 and a4 in-
tegrin that enable homing and maintenance of long-lived
plasma cells (Sciammas and Davis, 2004). Expression of
Blimp-1 after B cell activation is considered to be the
primary trigger for plasma cell differentiation and the
generation of antibody-secreting cells (ASC). Prdm1 ex-
pression is positively regulated by Stat3 and negatively
regulated by Bcl6 (Fujita et al., 2004; Reljic et al., 2000;
Shaffer et al., 2000; Tunyaplin et al., 2004). Thus, Bcl6
and Blimp-1 appear to represent a pair of counteracting
mutual repressors that play a pivotal role in regulating
the transition between alternative B cell states (Staudt,
2004).
AID (activation-induced deaminase; encoded by the
Aicda gene) is a cytidine deaminase that is essential for
SHM (somatic hypermutation) and isotype switching/
class switch recombination (CSR) (Muramatsu et al.,
2000). In vivo, expression of AID is generally restricted
to activated B cells undergoing affinity maturation and
CSR in germinal centers. AID is also expressed upon
polyclonal activation of B cells in vitro and results in
CSR in the absence of affinity maturation. Aicda expres-
sion is positively regulated by the transcription factors
E2A and Pax5 (Gonda et al., 2003; Sayegh et al., 2003).
IRF-4/Pip is a member of the interferon regulatory fac-
tor family of transcription factors characterized by a DNA
binding domain containing five conserved tryptophan
repeats (Escalante et al., 2002; Taniguchi et al., 2001).
In contrast to other IRF family members, expression of
IRF-4 is not regulated by type I or type II interferons. Its
expression is limited to lymphoid and myeloid cell types
(Eisenbeis et al., 1995; Marecki et al., 1999). Irf4 is an im-
mediate early gene in B as well as T lymphocytes whose
expression is induced by antigen receptor or mitogen
stimulation. It is constitutively and highly expressed in
plasma cells (Eisenbeis et al., 1995; Matsuyama et al.,
1995). IRF-4 is most closely related to IRF-8/ICSBP in
terms of primary structure and pattern of cellular expres-
sion. High-affinity DNA binding by IRF-4 has been ob-
served only when interacting with partners of the Ets
family (PU.1 or SpiB) or the helix-loop-helix family (E2A)
of transcription factors (Brass et al., 1999; Eisenbeis
et al., 1995; Nagulapalli and Atchison, 1998).
IRF-4 functions redundantly with IRF-8 to regulate pre-
B cell cycling and differentiation into immature sIgM+ B
cells (Lu et al., 2003). In contrast, IRF-4 functions in
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tion as well as terminal differentiation (Mittrucker et al.,
1997). Irf42/2 mice display low serum immunoglobulin,
and immunization fails to elicit antigen-specific anti-
bodies. This is despite the presence of normal numbers
of mature B cells in the secondary lymphoid organs.
While Irf42/2B lymphocytes produce low levels of immu-
noglobulins in vivo and in vitro, the nature of the molec-
ular pathways by which IRF-4 regulates isotype switch-
ing, Ig secretion, and/or plasma cell differentiation
remain to be elucidated.
We find that Irf42/2 B cells are severely compromised
for isotype switching and plasma cell generation as a
consequence of the failure to properly induce expression
of the Aicda and Prdm1 genes, respectively. Genome-
wide expression analysis demonstrates that IRF-4 regu-
lates the induction of the entire Blimp-1-dependent
plasma cell program. Restoration of AID and Blimp-1
expression promotes isotype switching and antibody
secretion, respectively, indicating that these regulatory
molecules are limiting in Irf42/2 B cells. IRF-4 is ex-
pressed in a stepwise manner during B cell differentia-
tion, and its higher concentration functions to induce
the Prdm1 gene, an IRF-4 target. We propose a gene-
regulatory network that can account for the develop-
mental coordination of CSR and plasma cell differentia-
tion based on graded expression of IRF-4.
Results
Irf42/2 B Lymphocytes Are Defective in the
Development of ASC as Well as CSR
To analyze the differentiation defects of the Irf42/2 B
cells, we employed quantitative in vitro assays that
measure the capacity for plasma cell differentiation, Ig
secretion, and isotype switching. These included flow
cytometric detection of Syndecan-1, IgG3, and IgG1 ex-
pression, as well as ELISA and ELISpot assays. Purified
splenic B cells were stimulated with LPS, which leads to
Syndecan-1 expression and isotype switching to IgG3,
or with LPS and IL-4 (LPS+IL-4), which leads to isotype
switching to IgG1 (Snapper and Paul, 1987). Because
the capacity to undergo isotype switching and to se-
crete is correlated with the number of cell divisions,
we monitored the latter via CFSE (Tangye and Hodgkin,
2004). In all experiments, we compared splenic B cells
from Irf4+/2 with Irf42/2 littermates because the hetero-
zygous mice are phenotypically normal (Mittrucker et al.,
1997). We observed a marked reduction in the genera-
tion of Syndecan-1-expressing cells in LPS-stimulated
cultures of Irf42/2 B cells (Figure 1A). Syndecan-1 is
a marker of ASC (Hasbold et al., 2004). In addition, a
severe defect was observed in CSR to IgG3 or IgG1
(Figure 1A). Similar results were obtained when Irf42/2
B cells were stimulated with CD40 ligand and IL-4
(CD40L+IL-4, data not shown). Antibody production by
Irf42/2 B cells was analyzed by ELISA. Irf42/2 B cells
secreted IgM at 1% of the levels observed with their
heterozygous counterparts (Figure 1B). Irf42/2 B cells
also generated 95% fewer antibody-secreting precursor
cells as measured by ELISpot analysis, an assay that
enumerates antibody-secreting clones directly (Fig-
ure 1C). Furthermore, we observed that the mean spot
size of the Irf42/2 ASC was about 3-fold reduced, sug-gesting a decreased secretory output (10.8 6 2.2 mm2
versus 3.5 6 1 mm2) (Hasbold et al., 2004). Collectively,
these results demonstrate that IRF-4 regulates both
isotype switching and plasma cell differentiation in a
cell-autonomous manner.
Failure of Irf42/2BCells to Switch or Secrete Ig Is Not
Due to a Defect in Undergoing Multiple Cell Divisions
It should be noted that Irf42/2 B cells properly regulate
the cell-surface markers CD25, CD69, CD62L, CD23,
CD80, CD86, and MHCII after acute stimulation (see
Figure S1A in the Supplemental Data available with this
article online) and CD44, CD62L, and CD23 upon pro-
longed stimulation (Figure S1B). Curve fitting analysis
of the CFSE histograms of LPS-activated cells revealed
that while many of the Irf42/2 B cells progress through
multiple cell divisions normally, the number of cells pres-
ent in later divisions (division five through seven) are re-
duced as compared to Irf4+/2 B cells (Figure S2A). This
was borne out by cell yield (Figure S2B). In contrast,
many more Irf42/2 B cells progressed through late cell
divisions, and the cell yields were improved when the
LPS stimulations were supplemented with IL-4 (Figures
S2A and S2B). To rigorously examine the cell-cycle dy-
namics and proliferative capacity of the Irf42/2 B cells,
we compared DNA synthesis and cell-cycle distributions
in LPS and LPS+IL-4 cultures. Purified splenic B cells
were pulsed with bromodeoxyuridine (BrdU) at days 1,
2, and 3 of stimulation, and incorporation was measured
by flow cytometry of fixed cells and analyzed in conjunc-
tion with DNA content by propidium iodide (PI) staining.
Although the overall cell-cycle profiles of the mutant cells
were similar to their control counterparts, Irf42/2 B cells
consistently incorporated less BrdU at day 2 (70% 6
12%, n = 7, p < 0.01, Figure S2C). We also observed an
increase in the number of Irf42/2 B cells containing less
than 2N DNA content (sub-G1 population) during the
late phase of stimulation (day 3 sub-G1, 2.2- 6 0.8-fold,
n = 7, p < 0.02). The sub-G1 population is characteristic
of apoptotic cells. These data along with lower cell yields
suggest that Irf42/2 B cells may be more prone to apo-
ptosis during the expansion phase. Nevertheless, these
data demonstrate that IRF-4 is neither required for the
induction of activation-associated cell-surface markers
nor for multiple cell divisions. Thus, the failure of Irf42/2
B cells to generate ASC or isotype-switched B cells is
not due to an inability to undergo multiple cell divisions.
IRF-4 Regulates Aicda and Prdm1 Expression
Since CSR is regulated by the induction of AID expres-
sion, the levels ofAicdamRNA were analyzed with quan-
titative RT-PCR. Aicda mRNA expression was impaired
in Irf42/2 B cells (Figure 2A). To determine whether the
failure in CSR was specifically due to diminished Aicda
expression, we analyzed IgM and IgG1 germline tran-
scripts by RT-PCR, after LPS+IL-4 stimulation (Fig-
ure 2B). The relative expression levels of IgM and IgG1
germline transcripts (GLT) were unaffected in the Irf42/2
B cells. In contrast, there was a marked reduction in
expression of the IgG1-switched transcripts in the ab-
sence of IRF-4, suggesting that a step downstream of
locus accessibility, namely AID-dependent DNA recom-
bination, was impaired. Importantly, Irf42/2 B cells were
not impaired for the expression of other CSR genes
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227Figure 1. Irf42/2 B Cells Are Defective in Isotype Switching and in the Generation of Antibody-Secreting Cells
Splenic B cells from Irf4+/2 and Irf42/2 mice were purified, labeled with CFSE, and stimulated with LPS or LPS+IL-4 for 4 days.
(A) Flow cytometric analysis of division-linked differentiation monitored by the expression of Syndecan-1 and IgG3 in LPS-stimulated cells (top)
or IgG1 in LPS+IL4-stimulated cells (bottom).
(B) Analysis of IgM secretion. Day 4 stimulated cells were harvested, washed, and cultured for 24 hr prior to isolating cell-free supernatants.
Secreted IgM was measured with sandwich ELISA.
(C) ELISpot analysis. Day 4 stimulated cells as described above were cultured for 24 hr on anti-IgM-coated membranes prior to ELISpot process-
ing. These experiments were repeated four times and representative results are shown; error bars correspond to the SEM of the replicates in the
ELISA and ELISpot assays.(Ung, Msh2), and they exhibited higher expression of
transcription factors required for CSR (Figure S3).
Thus, the defect in CSR manifested by Irf42/2 B cells
appears to be due to the selective impairment in Aicda
expression.Since the plasma cell differentiation program is regu-
lated by the induction of Blimp-1 expression, the levels
of Prdm1 mRNA and Blimp-1 protein were analyzed.
There was a striking failure to induce Prdm1 expression
in the absence of IRF-4 (Figures 2A and 2C). Consistent
Immunity
228Figure 2. Prdm1 and Aicda Expression Are Impaired in Irf42/2 B Cells
Splenic B cells from Irf4+/2 and Irf42/2 mice were purified and stimulated with LPS. RNA was isolated and used for quantitative RT-PCR.
(A) Relative expression of Aicda and Prdm1 transcripts at 2 and 4 days after stimulation, respectively. Three different primer pairs spanning the
indicated exons of the Prdm1 gene were used. Oct-1 transcripts were used for normalization. Data are from three independent experiments, and
error bars correspond to the SEM of the averages.
(B) RT-PCR analysis of m and g1 germline transcripts (GLT) and the post-switch g1 transcript from the IgG1 locus via serially diluted cDNAs
(5-fold).
(C) Expression of Blimp-1 protein (top) or Prdm1 mRNA (bottom) at 2 days after LPS stimulation. The immunoblot of nuclear extracts from stim-
ulated B cells of the indicated genotype was probed with Blimp-1 and IRF-8 antibodies and is representative of three independent experiments.
The average expression of Prdm1 transcripts by qPCR from three independent experiments is quantitated below; error bars correspond to the
SEM.
(D) RT-PCR analysis of membrane m(m) and secretory m(s) immunoglobulin transcripts with serially diluted cDNAs (3-fold). Results in (B) and (D)
are representative of three independent experiments.with the impaired expression of Blimp-1, Irf42/2 B cells
did not efficiently process IgH pre-mRNA to generate
transcripts encoding the secreted polypeptide, m(s)
(Figure 2D).
Genome-Wide Analysis Demonstrates that IRF-4
Regulates the Blimp-1-Dependent Plasma
Cell Differentiation Program
To analyze how loss of IRF-4 affects the transcriptional
program underlying B cell differentiation, we performed
genome-wide expression analysis with mouse lympho-
chips (Shaffer et al., 2004). Purified Irf4+/2 or Irf42/2 B
cells were cultured in the presence of LPS for 24, 48,
or 96 hr (Figure 3). Genes induced by at least 1.5-fold
in heterozygous B cells over untreated controls were
organized by hierarchical clustering. Irf42/2 B cells
showed no apparent defect in the induction of prolifera-
tion genes (Figure 3A). Second, the loss of IRF-4 did not
impair the induction or sustained expression of LPS-
responsive genes (Figure 3B).As expected by the impaired expression of Blimp-1, a
prominent subcluster of genes associated with plasma
cell differentiation was not expressed in Irf42/2 B cells.
Genes that were differentially expressed by greater
than 2-fold (p < 0.015) between Irf4+/2 and Irf42/2B cells
at day four of LPS stimulation are shown (Figure 3C).
These genes include immunoglobulins (both heavy and
light chains), as well as genes required for the elabora-
tion of the endoplasmic reticulum and secretory appa-
ratus (Xbp1 and its targets). Importantly, five genes
dependent on Blimp-1 but not Xbp1 also failed to be
induced in Irf42/2 B cells. In fact, by comparing these
profiles with the list of genes previously identified as re-
quiring Xbp1 and/or Blimp-1 for induction (Shaffer et al.,
2004), we find that the entire plasma cell gene expres-
sion program is defective in Irf42/2 B cells (Figure S4).
Overall, the gene-expression analysis of Irf42/2 B cells
demonstrates that whereas the induction of proliferation
and LPS-responsive genes occurs normally, the initia-
tion of the Blimp-1-dependent plasma cell program is
severely compromised.
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229Figure 3. Irf42/2 B Cells Fail to Activate the Plasma Cell Gene-Expression Program
Purified splenic B cells from Irf4+/2 and Irf42/2mice were stimulated with LPS for the indicated times to induce plasma cell differentiation. Micro-
array results from sequence-verified elements representing genes that were induced at least 1.5-fold in heterozygous B cells. These elements
meet spot confidence criteria and are present on >90% of the arrays. Relative expression changes are indicated by the color bar. Data were
normalized to the average expression in purified, untreated (0 hr) B cells from both genotypes and analyzed by hierarchical clustering. Subclus-
ters of this hierarchy are shown.
(A) Proliferation cluster.
(B) LPS-inducible gene cluster.
(C) Plasma cell program genes expressed differentially by 2-fold or more, with a statistically significant difference (Student’s t test, p < 0.015)
between Irf4+/2 and Irf42/2 B cells at 96 hr post LPS induction.The Expression of Blimp-1 and AID Are Limiting
for Antibody Secretion and Isotype Switching
in Irf42/2 B Cells
To directly test whether the impaired induction of Blimp-
1 and AID accounts for the Ig secretion and switching
defects in Irf42/2 B cells, we transduced these cells
with retroviruses (with an IRES-GFP segment) express-
ing Blimp-1 or AID. An IRF-4 retrovirus was used as a
control to complement the Irf42/2 B cells. As shown in
Figure 4A, IRF-4 efficiently restored the capacity of the
Irf42/2 B cells to secrete IgM, as measured by ELISA
from supernatants of sorted GFP+ cells. Importantly,
Blimp-1 also induced a significant increase in secretion(6.4-6 4.6-fold, n = 3, p < 0.02) by the Irf42/2B cells (Fig-
ure 4A). Although the complementation with Blimp-1 was
less efficient (see Discussion), this result nevertheless
demonstrates that Blimp-1 can functionally bypass the
secretion defect in Irf42/2B cells. As shown in Figure 4B,
restoration of IRF-4 expression greatly increased the
ability of the GFP+ Irf42/2 B cells to switch to IgG1. Im-
portantly, expression of AID in the Irf42/2B cells also re-
sulted in a substantial increase in IgG1 (2.6- 6 0.6-fold,
n = 5, p < 0.03) generated by isotype switching. As ex-
pected, IRF-4 expression in the mutant B cells induced
the expression of Aicda and Prdm1 genes (Figure S5).
Collectively, these results demonstrate that AID and
Immunity
230Figure 4. Restoration of Blimp-1 or AID Expression in Irf42/2 B Cells Promotes Ig Secretion or Isotype Switching, Respectively
Splenic B cells from Irf42/2 mice were purified and stimulated with LPS+IL-4. After activation for 24 hr, the cells were transduced with retrovi-
ruses encoding the indicated cDNAs fused to an IRES-GFP segment. Two days posttransduction, the GFP+ cells were analyzed.
(A) Ig secretion by sorted GFP+ cells. After sorting, cells were cultured for 24 hr, and secreted Ig from supernatants was quantitated with sand-
wich ELISA. Results are representative of three independent experiments; error bars correspond to the SEM of the replicates in the ELISA.
(B) Flow cytometric analysis of isotype switching to IgG1. Representative results from five independent experiments are shown.
(C) Immunoblot analysis of HA-tagged IRF-4 proteins expressed in 293T cells.
(D and E) Complementation of Irf42/2 B cells with wild-type or mutant IRF-4 proteins. Irf42/2 B cells were transduced with retroviruses encoding
the indicated proteins and analyzed for Ig secretion as described in (A) and isotype switching as described in (B), respectively. The wild-type and
AS397-transduced cells exhibited an average of 80- and 105-fold induction of Ig secretion in four independent experiments. Both the wild-type
and AS397-transduced cells displayed an 8-fold increase in IgG1 expression (averaged over five experiments). The R98A,C99A mutant is defec-
tive in DNA binding. The AS397 mutant is defective for interaction with PU.1 or SpiB. Results in (D) and (E) are representative of four and five
experiments, respectively; error bars in (D) correspond to the SEM.Blimp-1 expression are limiting in Irf42/2 B cells and
therefore substantially account for the defects in CSR
and plasma cell differentiation, respectively.
The DNA Binding Domain of IRF-4 but Not Its
PU.1/SpiB Interaction Surface Is Required
for CSR and Ig Secretion
To analyze the mechanism of IRF-4 function in B cells,
two mutant IRF-4 constructs were tested in the comple-
mentation assay. IRF-4 R98A,C99A does not bind DNA,and IRF-4 AS397 has a 4 residue mutation that disrupts
IRF-4’s interaction with PU.1 or SpiB (Brass et al., 1999).
Each of the constructs expressed IRF-4 protein at simi-
lar amounts as judged by immunoblotting of transiently
transfected 293T cells (Figure 4C). When transduced
into Irf42/2 B cells stimulated with LPS+IL-4, the DNA
binding mutant failed to induce secretion or isotype
switching (Figures 4D and 4E). In contrast, the PU.1/
SpiB binding mutant was able to restore both secretion
and isotype switching (Figures 4D and 4E). These results
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tion with PU.1 or SpiB, is required for induction of Ig
secretion and isotype switching.
Graded Expression of IRF-4 Functions to Regulate
CSR and Plasma Cell Differentiation
Paradoxically, IRF-4 positively regulates both Aicda and
Prdm1 expression even though they are key compo-
nents of antagonistic developmental states. We rea-
soned that varied expression of IRF-4 might differentially
regulate the expression of Aicda and Prdm1 genes. Ac-
cording to this model, a higher concentration of IRF-4
is required for Prdm1 upregulation and thus Blimp-1-
dependent repression of the germinal center program,
including the Aicda gene. To explore this possibility,
we analyzed the expression of IRF-4 protein in primary
wild-type cells during the course of LPS- or CD40L+IL-
4-induced B cell activation and differentiation by per-
forming intracellular flow cytometry. After induction,
IRF-4 expression was sustained through multiple cell
divisions (Figure 5A). Strikingly, we observed a division-
linked appearance of an IRF-4 high-expressing popula-
tion. In fact, costaining with Syndecan-1 revealed that
the Syndecan-1-positive cells also exhibited uniformly
high IRF-4 expression (Figure 5B). These results demon-
strate that the differentiation of activated B cells into
plasma cells is associated with a substantial increase
in IRF-4 protein.
To test whether overexpression of IRF-4 can augment
plasma cell differentiation, wild-type splenic B cells,
stimulated with CD40L+IL-4, were transduced with con-
trol or IRF-4-encoding retroviral vectors. IRF-4 aug-
mented the generation of Syndecan-1-expressing cells
(Figure 5C) and Ig secretion (Figure 5D). In fact, the
amounts of secreted Ig achieved by IRF-4 transduction
were similar to that attained by transduction of Blimp-1
expression vector (Figure 5D). Importantly, as predicted
by our model, elevated expression of IRF-4 resulted in
upregulation of the Prdm1 and the downregulation of
Aicda genes (Figure 5D). To further test whether high
concentrations of IRF-4 expression are essential for
plasma cell differentiation, we complemented Irf42/2
cells with the IRF-4 retroviral vector and analyzed GFP
expression as a surrogate for IRF-4 in the resulting Syn-
decan-1+ plasma cells. Strikingly, the rescued Synde-
can-1+ cells exclusively expressed very high amounts
of GFP, indicating that a low concentration of IRF-4 is in-
sufficient to initiate the plasma cell program (Figure 5C,
bottom). It should be noted that IRF-4 transduction of
wild-type B cells resulted in a broader range of GFP ex-
pression in Syndecan-1+ cells (Figure 5C, top). Overex-
pression of IRF-4 increased the relative proportion of
Syndecan-1+ cells in the bottom 75% of the GFP+ distri-
bution. This ratio changed from 1.8 6 0.05 to 1.5 6 0.02
(n = 2). We suggest that these cells require lower con-
centration of ectopically expressed IRF-4 to initiate the
plasma cell program due to endogenously expressed
IRF-4 and the amplification provided by a positive regu-
latory loop with Blimp-1 (see model below). Finally, in
rescue experiments with the same IRF-4 vector, and ex-
amining Ig class switching (Figure 4B, bottom), we note
that an intermediate concentration of IRF-4 appears suf-
ficient for inducing AID expression and isotype switch-
ing to IgG1. Collectively, these experiments supportour model that proposes graded expression of IRF-4
functions to differentially regulate Aicda and Prdm1
gene expression and consequently CSR and plasma
cell differentiation.
Elevated Expression of IRF-4 Induces a Germinal
Center to Plasma Cell Transition in a Human
B Cell Line
To test the role of IRF-4 in initiating a transition from the
germinal center to the plasma cell program of gene ex-
pression, we examined the consequences of elevating
the expression of IRF-4 in a human germinal center
B cell (GCB)-derived cell line, Oci-Ly7 (Shaffer et al.,
2002). IRF-4 transduction induced the expression of
CD38, which is expressed on human plasma cells (Fig-
ure 5E). Increased IRF-4 expression also resulted in
the induction of the key regulators of plasma cell differ-
entiation, Blimp-1 and Xbp1 and many of their target
genes (Figure 5F, Figure S6). Consistent with the induc-
tion of Blimp-1, we observed the repression of a large
cohort of genes expressed in germinal center B cells,
including Bcl6, Pax5, SpiB, and Aicda (Figure 5F,
Figure S6; Shaffer et al., 2002). The expression of the
Blimp-1 target c-MYC (Lin et al., 1997) was not substan-
tially changed, likely due to a chromosomal abnormality
at the c-MYC locus in this tumor line that relieves c-MYC
from its proper regulation. These findings demonstrate
that high concentration of IRF-4 can induce Prdm1 ex-
pression and the transition from a germinal center B
cell state to a plasma cell program of gene expression.
IRF-4 Interacts with a Conserved Region
in the Prdm1 Gene
To determine whether the Aicda and Prdm1 genes are
directly regulated by IRF-4, we surveyed conserved re-
gions of these genes by chromatin crosslinking and im-
munoprecipitation (ChIP). In these experiments involv-
ing naive and activated B cells, IRF-4 crosslinking to
the Ig lambda 30 enhancer was used as a positive control
(Figure 6; Lu et al., 2003). We did not observe crosslink-
ing of IRF-4 to three conserved noncoding sequences
(CNS) of the Aicda gene, including the promoter (Lee
et al., 2006) and an intronic enhancer (Figure S7, data
not shown; Sayegh et al., 2003). Importantly, IRF-4
crosslinking was detected to CNS 9 between exons 5
and 6 of the Prdm1 gene (Figure 6, Figure S7) but not
to CNS 1-8. This interaction was dependent upon B
cell activation, and the efficiency of crosslinking was
similar to that observed with the Ig lambda enhancer.
These data demonstrate that the Prdm1 gene is a direct
IRF-4 target.
Discussion
The defect in CSR manifested by Irf-42/2B cells is due to
a failure to induce sufficient levels of Aicda expression.
Ectopic expression of AID in the mutant cells promotes
CSR. Consistent with this observation, Irf42/2 B cells,
upon activation, express wild-type levels of germline
transcripts from the Cm and Cg1 regions of the IgH locus,
indicating that the failure to undergo CSR is not due to
impaired accessibility of the switch regions to AID. Fur-
thermore, expression of other transcription factors re-
quired for CSR (e.g., Pax5, Bach2, E2A) is not affected
Immunity
232Figure 5. IRF-4 Is Expressed in a Biphasic Manner in B Cells and High Levels Function to Induce Plasma Cell Differentiation
Splenic B cells from wild-type mice were purified and labeled with CFSE prior to stimulation with LPS or CD40L+IL-4.
(A) 4 days after stimulation, cells were processed for intracellular staining with IRF-4 and goat IgG (control) antibodies and then analyzed by flow
cytometry. Specific staining by the IRF-4 antibodies was confirmed with Irf42/2 B cells (data not shown).
(B) IRF-4-stained cells were costained with Syndecan-1 in order to analyze the plasma cell population. Results in (A) and (B) are representative of
four experiments.
(C) Purified splenic B cells from Irf4+/+ and Irf42/2 mice were stimulated with CD40L+IL-4 and transduced with retroviruses encoding the indi-
cated cDNAs fused to an IRES-GFP segment. 2 days posttransduction, the cells were analyzed for GFP and Syndecan-1 expression by flow
cytometry. IRF-4 transduction of wild-type B cells resulted in a 3.1- 6 0.5-fold increase in Syndecan-1-expressing cells (n = 3). Indicated gates
represent the 75th percentile and below of the GFP+ cells.
(D) Splenic B cells were activated and transduced as above. 2 days posttransduction, the GFP+ cells were sorted and cultured for 24 hr to analyze
IgM secretion (left) and Aicda and Prdm1 transcripts (right) as described in Figures 1 and 2.
(E) Flow cytometric analysis of CD38 expression in the human Oci-Ly7 germinal center-like DLBCL cell line transduced with control or human
IRF-4 retroviruses.
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233by the loss of IRF-4. Our results strongly suggest that
the primary cause of the CSR defect in Irf42/2mice (Mit-
trucker et al., 1997) is the impaired expression of Aicda.
It remains to be determined whether Aicda is an IRF-4
target gene.
The Prdm1 gene is bound by IRF-4 upon B cell activa-
tion. Of nine CNSs interrogated by ChIP, only CNS 9 in
the fifth intron of the Prdm1 gene was efficiently cross-
linked by IRF-4. Interestingly, Bcl6 has also been shown
to crosslink to this region of the Prdm1 gene (Tunyaplin
et al., 2004). Two putative IRF sites exist in this region,
and they are not composite elements that could be rec-
ognized additionally by PU.1 or Spi-B. This is in keeping
with the observation that the PU.1 interaction-defective
mutant of IRF-4 (AS397) is capable of rescuing the
plasma cell defect manifested by Irf42/2B cells. The mo-
lecular mechanism by which IRF-4 regulates the Prdm1
gene via this CNS remains to be elucidated.
We demonstrate that the failure of the Irf42/2B cells to
undergo plasma cell differentiation is due to impaired
induction of the Prdm1 gene. Multiple lines of experi-
mental evidence support the conclusion that IRF-4 pos-
itively regulates Blimp-1 expression. (1) Irf42/2B cells fail
to induce the entire plasma cell gene-expression pro-
gram, which is dependent on Blimp-1. In fact, the molec-
ular signature of LPS-activated Irf42/2B cells resembles
that ofPrdm12/2B cells and notXbp12/2B cells (Shaffer
et al., 2004). (2) Irf42/2 B cells do not efficiently process
the IgH pre-mRNA to generate the secretory m(s) tran-
script. Blimp-1 has been previously shown to specifi-
cally regulate this RNA-processing function, although
the mechanism remains elusive (Sciammas and Davis,
2004; Shapiro-Shelef et al., 2003). (3) Syndecan-1 induc-
Figure 6. IRF-4 Crosslinks to a Conserved Region in the Prdm1
Gene
Splenic B cells were purified and processed for chromatin immuno-
precipitation before and after LPS stimulation. Immunoprecipitated
DNA corresponding to conserved noncoding sequences (CNS) of
the Prdm1 locus (Figure S7A) was analyzed by quantitative PCR
and the results are displayed as percent of input. The lambda light
chain 30 enhancer was used as a positive control. Data are from
two independent experiments and the error bars represent the
SEM of the averages.tion is defective in LPS-stimulated Irf42/2 B cells. (4) Ec-
topic expression of IRF-4 in primary murine B cells upre-
gulates Prdm1 expression and Ig secretion. (5) Ectopic
expression of IRF-4 in a human B lymphoblastoid cell
line upregulates Prdm1 expression and the plasma cell
gene-expression program. (6) IRF-4 crosslinks to a con-
served noncoding sequence in thePrdm1gene. Our data
and conclusion concerning IRF-4 regulation of Blimp-1
expression differs from that in a recent report (Klein
et al., 2006). Although Klein et al. also observed profound
defects in CSR and plasma cell differentiation via a newly
generated Irf4 mutant allele, they attributed the latter
defect to a failure to express Xbp1 and not Blimp-1.
Our conclusion is based not only on expression analysis
of Prdm1 transcripts and Blimp-1 protein in Irf42/2 B
cells but also on the multiple lines of evidence cited
above. Finally, our conclusion is strongly complemented
by the findings that the transcription factor Mitf, which is
highly expressed in naive B cells, represses the expres-
sion of Irf-4 and precocious plasma cell differentiation
(Lin et al., 2004). Mutation of the Mitf gene results in the
derepression of Irf-4 expression, along with spontane-
ous B cell activation, antibody secretion, and autoanti-
body production. Inhibition of IRF-4 expression with an-
tisense oligonucleotides suppresses the spontaneous
antibody-secretion phenotype of MitfMi/Mi B cells. Thus,
precocious expression of IRF-4 likely results in prema-
ture induction of Blimp-1 and the onset of plasma cell
differentiation.
In spite of IRF-4 regulating Prdm1 expression, it ap-
pears that not all of the functions of IRF-4 in plasma cells
can be attributed to Blimp-1. Although Blimp-1 can
complement the Ig secretion defect of Irf42/2 B cells, it
does so inefficiently. We note that the Blimp-1 expres-
sion vector used in these experiments induces efficient
Ig secretion in B cell lines and primary B cells (Sciammas
and Davis, 2004). Therefore, IRF-4 could regulate Ig
secretion independently of, or in a synergistic manner
with, Blimp-1.
The plasma cell phenotype of Irf42/2 B cells is similar
to that of Prdm12/2 B cells (Shapiro-Shelef et al., 2003)
but distinct from those manifested by mutations in the
Pou2f2 (Oct-2), Pou2af1 (Obf1/OcaB/Bob1), or Cdkn2c
(p18) genes (Corcoran et al., 2005; Corcoran and Karve-
las, 1994; Tourigny et al., 2002). Pou2f22/2 B cells are
blocked at the G1 to S phase transition, fail to properly
upregulate activation markers, and undergo exagger-
ated cell death (Corcoran and Karvelas, 1994). OBF-1
appears to play a selective role in regulating the devel-
opment of ASC, because fewer Blimp-1-positive plasma
cells are generated in the context of T-dependent but
not T-independent responses in Pou2af12/2 mice (Cor-
coran et al., 2005). Cdkn2c2/2 B cells fail to exit the cell
cycle and consequently are impaired for Ig secretion
(Tourigny et al., 2002). In contrast, IRF-4 appears to rep-
resent an obligate and intimate regulator of plasma cell
differentiation.
IRF-4 functions redundantly with IRF-8 to limit the
clonal expansion of pre-B cells, which is driven by sig-
naling through the pre-BCR (Lu et al., 2003). In the(F) Quantitative RT-PCR analysis of selected genes from the cells described in (E). Average values from three independent experiments,
transcripts of each gene are normalized to the expression of USF2; error bars correspond to SEM. (C), (E), and (F) are representative of three
independent experiments, whereas (D) represents data from two independent experiments.
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cell-cycle arrest and do not differentiate into immature
B cells. By analogy, we propose that IRF-4 functions
in a nonredundant manner to limit the clonal expansion
of activated B cells by inducing cell-cycle arrest and
terminal differentiation into nondividing plasma cells.
Consistent with this proposal, IRF-4 is expressed in a
biphasic manner, with the highest concentration being
reached in plasma cells. The molecular pathways by
which IRF-4 inhibits the cell cycle in pre-B or plasma
cells remain to be elucidated. In plasma cells, IRF-4
may function to inhibit cell-cycle progression in part
via the induction of Blimp-1, which represses c-myc
and other proliferation-associated genes (Sciammas
and Davis, 2004; Shaffer et al., 2002).
How does IRF-4 regulate temporally distinct patterns
ofAicda andPrdm1gene expression and therefore coor-
dinate isotype switching with plasma cell generation?
Based on earlier analyses and the findings herein, we
assemble a minimal gene regulatory network in which
IRF-4 functions as a critical node in regulating the devel-
opmental transition from a germinal center B cell to a
plasma cell (Figure 7). During the onset of B cell differen-
tiation when IRF-4 concentrations are low, we propose
that it activates the Aicda gene in combination with the
transcription factor Pax5 (Gonda et al., 2003). We note
that theAicda gene may be indirectly regulated by IRF-4.
Pax5 expression at this stage prevents Blimp-1 induc-
tion by promoting the expression of Bcl6 (Nera et al.,
2006). Increased expression of IRF-4 induces Prdm1,
which, in turn, feeds back to augment expression of the
Irf4 gene. In addition to our own data, two lines of evi-
dence support the positive autoregulatory loop between
Blimp-1 and IRF-4. First, deletion of thePrdm1 gene in B
cells leads to a failure to sustain IRF-4 expression upon
LPS activation (Kallies et al., 2004). Second, ectopic ex-
pression of Blimp-1 in a B lymphoma (M12) that results in
expression of the plasma cell program and Ig secretion
also leads to a 4-fold induction of Irf4 expression (Sciam-
Figure 7. Proposed Gene-Regulatory Network Orchestrating the
Germinal Center to Plasma Cell Transition
The network depicts regulatory connections between four genes en-
coding transcription factors and the Aicda gene. Arrows represent
positive regulation and barred lines represent repression; dashed
lines indicate that a relationship could be indirect. As indicated,
the circuit architecture allows IRF-4 to differentially regulate AID
and Blimp-1 in competing cellular states. Importantly, the graded
expression of IRF-4, generated during the course of antigen-depen-
dent B cell differentiation, is proposed to promote the transition of
a germinal center B cell to the plasma cell state.mas and Davis, 2004). A key feature of the model is that
Bcl6 represses Prdm1 (Fujita et al., 2004; Reljic et al.,
2000; Shaffer et al., 2000; Tunyaplin et al., 2004). In turn,
Blimp-1 represses Bcl6 (Sciammas and Davis, 2004;
Shaffer et al., 2002) and Pax5 (Lin et al., 2002; Shaffer
et al., 2002) and thus the germinal center program of
gene expression, which includes the Aicda gene. Thus,
the proposed autoregulatory loop between IRF-4 and
Blimp-1 is suggested to overcome Bcl6-mediated re-
pression of thePrdm1gene. This mechanism would tem-
porally delay the activation of the Prdm1 gene in relation
to the Aicda gene by IRF-4. An attractive feature of our
regulatory network involving a positive autoregulatory
loop between IRF-4 and Blimp-1 is that it enables the
generation of a stable differentiated state (plasma cell)
that requires inducing signals (antigen receptor, TLR, cy-
tokines) for its establishment but not for its maintenance.
Experimental Procedures
Detailed methods are described in Supplemental Data.
Mice
The Irf42/2 mice have been previously described (Mittrucker et al.,
1997). Mice were housed in specific pathogen-free conditions and
were used and maintained in accordance with the Institutional Ani-
mal Care and Use Committee guidelines.
Cells and Culture Conditions
Splenic B cells were isolated by sequential hypotonic lysis of RBC
and magnetic bead separation of non-B cells with a biotin-coupled
cocktail of T, NK, macrophage, and granulocyte-specific antibodies,
followed by adsorption to Streptavidin microbeads (Miltenyi Biotec
Inc.). The unbound cells (typically greater than 90% B220+) were
washed and placed into culture with LPS, IL-4, or CD40L. Cell divi-
sions were monitored by labeling the purified B cells with 1.5 mM
CFSE (Molecular Probes). Retroviral infections were performed
24 hr after stimulation, and GFP+ cells were sorted 48 hr after infec-
tion. The germinal center B cell line Oci-Ly7 was cultured and trans-
duced as described (Shaffer et al., 2002).
DNA Constructs
The murine IRF-4 retroviruses were constructed by subcloning
HA-tagged cDNA segments into the MigR1 retrovirus that contains
an IRES-GFP segment. The Blimp-1 retrovirus has been previously
described (Sciammas and Davis, 2004), and the AID retrovirus was
a kind gift from F. Livak (University of Maryland). The HA-IRF-4
mDBD binding mutant was constructed by changing four nucleo-
tides to confer insertion of a restriction site and codons for two ala-
nine mutations at positions 98 and 99 of the protein with the Quick-
change site-directed mutagenesis kit (Stratagene). The HA-IRF-4
AS397 mutation consists of a linker scanning mutation changing
four amino acids to alanines starting at position 397 of the protein
and has been previously described (Brass et al., 1999). The human
IRF-4 retrovirus consists of a FLAG-tagged IRF-4 cDNA expressed
by the vector Vxy-puro (Shaffer et al., 2004).
ELISA and ELISpot
Secreted IgM was analyzed by harvesting and washing cells from
day 3 or 4 stimulated cultures and plating at 1 3 106 cells/ml for an
additional day, prior to analyzing supernatants by ELISA as de-
scribed (Sciammas and Davis, 2004). Antibody-secreting cells were
enumerated with an ELISpot technique by preparing cells as above
and plating serial dilutions of cells in triplicate on anti-IgM-coated
ELISpot plates (Millipore). After washing, the spots were detected
with a horseradish peroxidase-coupled anti-IgM and finally devel-
oped with AEC substrate (Sigma). The spots were counted with the
CTL Analyzer powered by ImmuoSpot Software (Cellular Technol-
ogy, Ltd.). All ELISA and ELISpot antibodies were purchased from
Jackson Immunoresearch.
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The PlatE packaging cells were transiently transfected with retroviral
constructs with the Fugene6 reagent (Roche) to produce viral super-
natants.
Flow Cytometry
Cells were washed in staining buffer, PBS containing BSA (0.5%, w/v)
and sodium azide (0.05%, w/v), and blocked with anti-FcR (clone
2.4G2) hybridoma supernatant. Cells were stained with biotin- or
fluorochrome-coupled antibodies in staining buffer according to
standard procedures. Antibodies specific for murine Syndecan-1,
IgG3, IgG1, B220, CD23, CD62L, CD44, CD25, CD80, CD86, BrdU,
and isotype controls, as well as antibodies specific for human
CD10 and CD38 were purchased from BD Pharmingen. Data were
collected with either the LSR II or FACSVantage. Dead cells were
excluded by DAPI. Data were analyzed with the FlowJo software
(Tree Star, Inc.). Intracellular detection of IRF-4 was performed by
sequential labeling with Live/Dead Fixable Blue (UV excitable) Stain
(Molecular Probes), followed by staining for extracellular markers
and fixation. The fixed cells were permeabilized with Saponin (Sigma)
and stained with anti-IRF-4 or goat IgG (Santa Cruz Biotech.)
followed by a Cy5-coupled anti-goat secondary.
Cell Lysate Preparation and Immunoblotting
Whole-cell lysates were prepared after washing cells with PBS and
resuspending cells in detergent lysis buffer containing protease
inhibitors. Preparation of nuclear extracts was performed as de-
scribed (Sciammas and Davis, 2004). Proteins were resolved by de-
naturing SDS-PAGE and transferred to nitrocellulose. The blots were
probed with Blimp-1 (Kallies et al., 2004), IRF-8 (Santa Cruz), or HA
antibodies (Covance) and visualized with appropriate HRP-coupled
secondary antibodies.
RNA Analysis by RT-PCR
Total RNA was isolated with Trizol (Invitrogen), quantitated, and
used to make cDNA. Quantitative PCR was performed in duplicate
with a SYBR green kit (Stratagene) or a TaqMan RT-PCR kit (ABI).
Gene-specific and intron-spanning primers were validated for the
generation of unique products. Semiquantitative PCR was used to
analyze the expression of germline and post-switch transcripts as
described (Muramatsu et al., 2000) or for the membrane and the
secretory forms of IgM transcripts (Reimold et al., 2001).
Microarray Analysis
For microarray analysis, experimental RNAs were converted to
Cy5-labeled cDNA and cohybridized on mouse lymphochip arrays
with RNA from a reference pool labeled with Cy3 (see http://
lymphochip.nih.gov/ShafferPCfactors/). Microarray experiments
with the control and IRF-4-transduced human cell line Oci-Ly7 in-
volved cohybridization of the differentially labeled RNA samples
on human lymphochip arrays (Shaffer et al., 2002). Microarray data
analysis was performed with the Cluster and Treeview programs.
Only data from sequence-verified elements are displayed.
Chromatin Immunoprecipitation
ChIP was perfomed on 2.5 3 106 cells with conditions optimized for
lymphocytes (Lu et al., 2003). DNA was sonicated with three pulses
of 45 s each, and DNA fragmentation was monitored by agarose gel
electrophoresis and was typically in the range of 0.5 to 1 kb. Immu-
noprecipitation was performed with 1 mg of anti-IRF-4 or goat IgG
(Santa Cruz) and Protein G Sepaharose. SYBR green-based quanti-
titave PCR reactions were set up in duplicate to analyze the precip-
itated DNA for 40 cycles with primer sets known to generate unique
products. Standard curves were generated for each DNA segment
analyzed in each run. The relative IP efficiency was determined by
dividing the value of the immunoprecipitated sample with that of
the input sample and is displayed as percent of input. The back-
ground from control IgG samples averaged 0.05% 6 0.01%.
Supplemental Data
Supplemental Data include seven figures, one table, and Supple-
mental Experimental Procedures and can be found with this article
online at http://www.immunity.com/cgi/content/full/25/2/225/DC1/.Acknowledgments
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